Machado, Pedro M., Richard J. Barohn, Michael P. McDermott, Claus Sundgreen, Thomas Blaettler, Michael G. Hanna, and Mazen Dimachkie. “Design and Rationale for a Randomized, Double-Blind, Placebo-Controlled Phase 2 3 Trial of Oral Arimoclomol in Inclusion Body Myositis”. RRNMF Neuromuscular Journal 5, no. 2 (September 4, 2024). Accessed November 21, 2024. https://journals.ku.edu/rrnmf/article/view/16244.